Feb. 17, 2026

From Startup to Scale: Dr. Therese Canares on Selling While Navigating the FDA Approval Process

From Startup to Scale: Dr. Therese Canares on Selling While Navigating the FDA Approval Process
Apple Podcasts podcast player badge
Spotify podcast player badge
Overcast podcast player badge
Castro podcast player badge
PocketCasts podcast player badge
RSS Feed podcast player badge
Apple Podcasts podcast player iconSpotify podcast player iconOvercast podcast player iconCastro podcast player iconPocketCasts podcast player iconRSS Feed podcast player icon

Summary


In this conversation, Therese Canaris, CEO of Curie DX, discusses the innovative approach her company is taking to improve access to diagnostic tests in healthcare. She shares insights on the challenges of sales in the healthcare sector, the importance of customer discovery, and the need for building trust with healthcare providers. The conversation also touches on the complexities of navigating FDA approval, ensuring data security, and demonstrating the value and ROI of healthcare innovations.


Takeaways

  • Curie DX aims to improve access to diagnostic tests.
  • Sales in healthcare requires understanding customer needs.
  • Customer discovery is crucial for product development.
  • Building trust with healthcare providers is essential.
  • Demonstrating ROI is a key challenge in healthcare sales.
  • Navigating FDA approval is a lengthy process.
  • Data security and HIPAA compliance are critical.
  • Moms often make healthcare decisions for families.
  • Innovative solutions can drive patient traffic to providers.
  • The healthcare landscape is evolving with new regulations.

 

If you'd like to learn more about what we do, then please visit: